Beta Bionics officer plans sale of 2,660 shares

The shares are to come from stock-option exercises over the next three months, and three of the prior sales are labeled 10b5-1 sales.

Rhea-AI Filing Summary

Beta Bionics, Inc. (BBNX) officer Mark Hopman reported a planned sale of 2,660 common shares, listed with an aggregate market value of $50,486.80. Hopman states the shares are to be received through stock-option exercises over the next three months, with acquisition and payment dates corresponding to the exercise and sale dates. Morgan Stanley Smith Barney LLC is listed as broker. Four sales during the prior three months are also listed, three labeled as 10b5-1 sales.

Key Figures

Shares planned for sale: 2,660 shares Aggregate market value: $50,486.80 Prior sale: 30,779 shares; $619,641.13 +3 more

6 metrics

Shares planned for sale 2,660 shares Common shares

Aggregate market value $50,486.80 Planned sale

Prior sale 30,779 shares; $619,641.13 September 16, 2026

Prior sale 775 shares; $12,028.00 September 14, 2026

Prior sale 36,870 shares; $680,723.44 September 9, 2026

Prior sale 5,327 shares; $101,815.48 September 2, 2026

Key Terms

Rule 144, 10b5-1 Sales, Exercise of Stock Options

3 terms

Rule 144 regulatory

"the definition of "person" in paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

10b5-1 Sales regulatory

"10b5-1 Sales for MARK HOPMAN"

10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.

Exercise of Stock Options financial

"Exercise of Stock Options"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many BBNX shares does officer Mark Hopman plan to sell?

Mark Hopman plans to sell 2,660 common shares, listed with an aggregate market value of $50,486.80. He states the shares are to be received through stock-option exercises over the next three months.

What prior sales did Mark Hopman report for BBNX?

The listed sales were 30,779 shares for $619,641.13 on September 16, 2026; 775 shares for $12,028.00 on September 14, 2026; 36,870 shares for $680,723.44 on September 9, 2026; and 5,327 shares for $101,815.48 on September 2, 2026. The first three entries are labeled 10b5-1 sales.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/01/2026 - 04:30 PM Accepted by SEC EDGAR 10/01/2026 - 04:30 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002048497
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	BETA BIONICS, INC.
SEC File Number	001-42491
Address of Issuer	11 Hughes Irvine CALIFORNIA 92618
Phone	9494277785
Name of Person for Whose Account the Securities are To Be Sold	MARK HOPMAN
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	2660	50486.80	44989688	10/01/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/01/2026	Exercise of Stock Options	Issuer			2660	10/01/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for MARK HOPMAN 11 Hughes Irvine CA 92618	Common	09/16/2026	30779	619641.13
10b5-1 Sales for MARK HOPMAN 11 Hughes Irvine CA 92618	Common	09/14/2026	775	12028.00
10b5-1 Sales for MARK HOPMAN 11 Hughes Irvine CA 92618	Common	09/09/2026	36870	680723.44
MARK HOPMAN 11 Hughes Irvine CA 92618	Common	09/02/2026	5327	101815.48

144: Remarks and Signature

Remarks	The securities to be sold were and will be received upon the exercise of stock options over the next three months. The dates of acquisition and payment were and will be the dates of exercise/sale.
Date of Notice	10/01/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/10/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Mark Hopman
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)